DataMeds AI, Inc. Operating Cash Flow
DataMeds AI, Inc. (MEDS) reported Operating Cash Flow of -$6.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-17
- DataMeds AI, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.89M.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.41M.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.29M.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.14M, a 209.42% decline year-over-year.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$10.86M.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$1.22M.
- DataMeds AI, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$349.14K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$6.31M 10-Q · filed 2026-08-17 | -$12.60M derived: sum of 3 quarters · filed 2026-08-17 | -$13.74M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$3.41M 10-Q · filed 2026-05-19 | -$9.71M derived: sum of 2 quarters · filed 2026-05-19 | -$10.84M derived: sum of 3 quarters · filed 2026-05-19 | -$12.92M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$7.43M derived: sum of 2 quarters · filed 2026-03-20 | -$9.51M derived: sum of 3 quarters · filed 2026-08-17 | -$10.86M 10-K · filed 2026-03-20 |
| 2025-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$3.21M derived: sum of 2 quarters · filed 2026-08-17 | -$4.56M 10-Q · filed 2025-11-19 | -$7.19M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$3.43M 10-Q · filed 2026-08-17 | -$6.05M derived: sum of 3 quarters · filed 2026-08-17 | -$5.01M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$1.35M 10-Q · filed 2026-05-19 | -$3.97M derived: sum of 2 quarters · filed 2026-05-19 | -$2.93M derived: sum of 3 quarters · filed 2026-05-19 | -$2.60M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$1.59M derived: sum of 2 quarters · filed 2026-03-20 | -$1.26M derived: sum of 3 quarters · filed 2026-03-20 | -$1.22M 10-K · filed 2026-03-20 |
| 2024-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.37M derived: sum of 2 quarters · filed 2025-11-19 | $1.40M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $329.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $361.19K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | $31.24K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$349.14K 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |